| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2004.01.064 |
| P698 | PubMed publication ID | 15297067 |
| P50 | author | Jacques Chomilier | Q58634672 |
| P2093 | author name string | Zagury JF | |
| Boissier MC | |||
| Briand JP | |||
| Muller S | |||
| Cavaillon JM | |||
| Therwath A | |||
| Bessis N | |||
| Paturance S | |||
| Autin L | |||
| Bernier EM | |||
| Bertin-Maghit SM | |||
| Capini CJ | |||
| Haumont PM | |||
| Laborie MA | |||
| Muel EG | |||
| P2860 | cites work | The Protein Data Bank | Q24515306 |
| Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent | Q28191546 | ||
| Anti-TNF therapies in rheumatoid arthritis, Crohn's disease, sepsis, and myelodysplastic syndromes | Q33966333 | ||
| Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice. | Q34977290 | ||
| Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases | Q35090142 | ||
| C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis | Q35126948 | ||
| Biological functions of tumor necrosis factor cytokines and their receptors | Q35145609 | ||
| Histidine-15: an important role in the cytotoxic activity of human tumor necrosis factor | Q38344754 | ||
| Active anti-interferon-alpha immunization: a European-Israeli, randomized, double-blind, placebo-controlled clinical trial in 242 HIV-1--infected patients (the EURIS study). | Q40964230 | ||
| TNF-alpha transgenic and knockout models of CNS inflammation and degeneration | Q41355429 | ||
| Sensitizing effects of cadmium on TNF-alpha- and TRAIL-mediated apoptosis of NIH3T3 cells with distinct expression patterns of p53. | Q42811245 | ||
| Anti–IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics | Q47963812 | ||
| Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. | Q52221782 | ||
| Production of TNF by monocytes of patients with early rheumatoid arthritis is increased. | Q54619618 | ||
| Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists | Q56864876 | ||
| Tumour necrosis factor alpha and interleukin-2 in plasma from rheumatoid arthritis patients in relation to disease activity | Q67875311 | ||
| Comparative studies of the biological activities of human tumor necrosis factor and its derivatives | Q70187519 | ||
| Essential role of tumor necrosis factor-alpha in the differentiation of human tonsil in vivo induced B cells capable of spontaneous and high-rate immunoglobulin secretion | Q70669925 | ||
| A targeted DNA vaccine augments the natural immune response to self TNF-alpha and suppresses ongoing adjuvant arthritis | Q73163207 | ||
| The temporal importance of TNFalpha expression in the development of diabetes | Q73867591 | ||
| Induction of cross-reactive antibodies against a self protein by immunization with a modified self protein containing a foreign T helper epitope | Q74497673 | ||
| Active vaccination against IL-5 bypasses immunological tolerance and ameliorates experimental asthma | Q74532609 | ||
| Anti-IFN alpha immunization raises the IFN alpha-neutralizing capacity of serum--an adjuvant to antiretroviral tritherapy | Q77777249 | ||
| Therapeutic antibodies elicited by immunization against TNF-alpha | Q77995733 | ||
| P433 | issue | 23-24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | active immunization | Q3425478 |
| immunization | Q1415366 | ||
| P304 | page(s) | 3144-3153 | |
| P577 | publication date | 2004-08-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Active immunization against murine TNFalpha peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection | |
| P478 | volume | 22 |
| Q28554288 | A Rationally Designed TNF-α Epitope-Scaffold Immunogen Induces Sustained Antibody Response and Alleviates Collagen-Induced Arthritis in Mice |
| Q82081093 | Active immunization against IL-23p19 improves experimental arthritis |
| Q45069341 | Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers |
| Q42827899 | An IL-17 peptide-based and virus-like particle vaccine enhances the bioactivity of IL-17 in vitro and in vivo. |
| Q37340457 | Emerging applications of anticytokine vaccines |
| Q82223895 | Enhancement of IL-10 bioactivity using an IL-10 peptide-based vaccine exacerbates Leishmania major infection and improves airway inflammation in mice |
| Q37614491 | IL-1 Vaccination Is Suitable for Treating Inflammatory Diseases |
| Q36499879 | Immunization against an IL-6 peptide induces anti-IL-6 antibodies and modulates the Delayed-Type Hypersensitivity reaction in cynomolgus monkeys |
| Q37773295 | Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines |
| Q37850806 | Kinoid of human tumor necrosis factor-alpha for rheumatoid arthritis |
| Q91652147 | Peptide-Based Vaccination Therapy for Rheumatic Diseases |
| Q38120922 | Strategies for active TNF-α vaccination in rheumatoid arthritis treatment |
| Q35540023 | TNFalpha kinoid vaccination-induced neutralizing antibodies to TNFalpha protect mice from autologous TNFalpha-driven chronic and acute inflammation |
| Q35136750 | Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis |
| Q34452035 | Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis |
| Q43238854 | Targeting TGF-beta1 by employing a vaccine ameliorates fibrosis in a mouse model of chronic colitis |
| Q40485583 | Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis |
| Q37165366 | Vaccination with cytokines in autoimmune diseases |
Search more.